Today, the Federal Health and Aged Care Minister announced the listing of Vumerity® (diroximel fumarate) on the Pharmaceutical Benefits Scheme (PBS) for the treatment of Australians living with relapsing remitting MS (RRMS).
National Pain Week (July 25 to 31) is an annual event coordinated by Chronic Pain Australia. Pain is one of the less recognised symptoms of multiple sclerosis but affects around two-thirds of the over 25,600 Australians living with the disease.
This year marks the 50th year of Multiple Sclerosis Australia, an organisation formed to drive awareness, research, and support for people with multiple sclerosis (MS).
As we mark our 50th year, it's deeply encouraging to look at how far we have come over the past five decades and acknowledge the great changes that have taken place to improve the quality of life for people living with MS.
